InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,127.79
(
1.26%
)
US TECH 100
17,440.00
(
2.13%
)
Dow Jones
38,675.68
(
1.18%
)
Brent Oil
82.74
(
-1.06%
)
Bitcoin
62,910.37
(
6.41%
)
Post# of 251700
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 827
Posts 119559
Boards Moderated 15
Alias Born 09/05/2002

DewDiligence

Member Level

Re: willyw post# 182640

Friday, 10/10/2014 2:48:29 PM

Friday, October 10, 2014 2:48:29 PM

Post# of 251700
ENTA is up strongly today (IMO) because the Harvoni 8-week labeling is slightly more restrictive than some investors probably thought. The larger the proportion of Harvoni patients who take the drug for 12 weeks rather than 8 weeks, the more competitive ABBV/ENTA’s 3-DAA regimen will be on price, leading to a higher market share for ABBV/ENTA and larger royalties for ENTA.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up